期刊文献+

老年胃癌病人胃癌组织中Ki67、P53及Her2的表达及临床意义 被引量:6

Expression and clinical significance of Ki67,P53 and Her2 in elderly patients with gastric carcinoma
下载PDF
导出
摘要 目的探讨老年胃癌病人胃癌组织中Ki67、P53及Her2的表达及其临床意义。方法选取2016年1月至2017年5月期间在我院住院治疗的老年胃癌病人152例及其手术切除的病理组织标本,进行Ki67、P53及Her2检测,并对其和临床病理特征的关系进行分析。结果老年胃癌病人胃癌组织中Ki67、P53及Her2的阳性表达率分别为74.34%、58.55%、49.34%,均明显高于癌旁组织的阳性表达率,差异均有统计学意义(P<0.01)。临床分期为Ⅲ~Ⅳ期、有淋巴结转移、浸润深度为肌层和浆膜层的老年胃癌病人,其胃癌组织中Ki67、P53及Her2阳性表达率均明显升高(P均<0.05);未发现老年胃癌病人胃癌组织中Ki67、P53及Her2阳性表达率与性别、组织学分型有关(P>0.05)。结论 Ki67、P53及Her2均和老年胃癌的发生发展具有密切的关系,可以作为判定老年胃癌恶性程度及进展的重要参考指标。 Objective To investigate the expression and clinical significance of Ki67,P53 and Her2 in elderly patients with gastric carcinoma. Methods A total of 152 elderly patients with gastric carcinoma in our hospital from January 2016 to May 2017,and their surgical pathological specimens were selected. The expression and clinical significance rates of Ki67,P53 and Her2 were analyzed. Results The positive expression rates of Ki67,P53 and Her2 in elderly patients with gastric carcinoma were74. 34%,58. 55%,49. 34% respectively,which were significantly higher than those of peficancerous tissues( P0. 01). The positive expression rates of Ki67,P53 and Her2 in gastric carcinoma tissue were significantly higher in patients with clinical stage Ⅲ-Ⅳ,lymph node metastasis,infiltration depth of muscularis and serosa( P〈0. 05). There were no statistical differences in the positive expression rate of Ki67,P53,and Her2 between the different gender and histological type in elderly patients with gastric carcinoma( P〉0. 05). Conclusions Ki67,P53 and Her2 are closely related to the occurrence and development of gastric carcinoma in elderly patients,and it can be used as an important index to determine the malignant degree and progression of elderly patients with gastric carcinoma.
作者 张功学 齐峰 丁凯 杨阳 马飞 ZHANG Gong-xue;QI Feng;DING Kai;YANG Yang;MA Fei(Department of Pathology, Zaoyang First People's Hospital, Zaoyang 441200, China)
出处 《实用老年医学》 CAS 2018年第5期443-446,共4页 Practical Geriatrics
关键词 胃癌 老年人 KI67 P53 Her2 gastric carcinoma aged Ki67 P53 Her2
  • 相关文献

参考文献4

二级参考文献41

  • 1无,房静远(整理者),刘文忠(整理者),施尧(整理者),戈之铮(整理者),萧树东(整理者).中国慢性胃炎共识意见(2006年,上海)[J].中华消化内镜杂志,2007,24(1):58-63. 被引量:84
  • 2Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002[J]. CA Cancer J Clin, 2005, 55(2):74-108.
  • 3Cunningham D, Starling N, Rao S, et al. Capecitabine and oxaliplatin for advanced esophagogastric cancer [ J ]. N Engl J Med,2008,358( 1 ) :36-46.
  • 4Kang YK, Kang WK, Shin DB, et al. Capecitabine/cisplatin versus 5-fluorouracilfcisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase Ⅲ noninferiority trial [ J ]. Ann Oncol, 2009, 20 ( 4 ) : 666-673.
  • 5Koizumi W, Akiya T, Sato A, et al. Phase Ⅱ study of S-1 as first-line treatment for elderly patients over 75 years of age with advanced gastric cancer: the Tokyo Cooperative Oncology Group study [J]. Cancer Chemother Pharmacol, 2010,65(6): 1093-1099.
  • 6Koizumi W, Narahara H, Hara T, et al. Randomised con- trolled trial of S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial ): a phase Ⅲ trial[J]. Lancet Oncol, 2008, 9(3) :215-221.
  • 7Tsuji A, Shima Y, Morita S, et al. Combination chemotherapy of S-1 and low-dose twice-weekly cisplatin for advanced and recurrent gastric cancer in an outpatient setting: a retrospective study [J]. Anticancer Res, 2008, 28 (2B) : 1433-1438.
  • 8Lee JL, Kang YK, Kang H J, et al. A randomised multicentre phase Ⅱ trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer [J]. Br J Cancer, 2008, 99(4):584-590.
  • 9Jass JR, Filipe MI. A variant of intestinal metaplasia associ- ated with gastric carcinoma : a histochemical study [ J ]. His- topathology, 1979,3 ( 3 ) : 191-199.
  • 10Schlemper Ill, Riddell RI-I, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia [ J ]. Gut, 2000,47(2) :251-255.

共引文献38

同被引文献36

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部